Kronik obstrüktif akciğer hastalığı, kronik hava yolu obstrüksiyonu ve hiperinflasyon ile karakterize bir grup akciğer hastalığıdır. Farmakolojik ve farmakolojik olmayan tedavi algoritmaları sunan kanıta dayalı tedavi yaklaşımı incelemeleri yayımlanmıştır. Son birkaç on yılda, özellikle amfizemli hastalar için olmak üzere, farmakolojik olmayan ek tedavi yöntemlerinin geliştirilmesine yönelik birçok çalışma yapılmıştır. Üç farklı endoskopik hacim küçültme yöntemi umut vaat etmiştir ve heterojen amfizemli hastalar üzerinde yürütülen ileri faz klinik çalışmalara ulaşılmıştır. Bu üç yöntem, geri çevrilebilir hava yolu bloke etme tekniklerini, hava yolunu bloke etmeyen geri çevrilebilir teknikleri ve hava yolunu bloke etmeyen geri çevrilemeyen t...
mphysema is an irreversible disease and although patients derive significant benefit from inhaled th...
Chronic obstructive pulmonary disease remains one of the most common causes of morbidity and mortali...
The conventional medical management of emphysema using bronchodilators and anti-inflammatory agents ...
Chronic obstructive pulmonary disease is a group of lung diseases characterized by chronic airflow o...
Severe emphysema is an important problem, affecting ~10 % of people in the USA and is the fourth lea...
Limited guidance exists for the implementation of lung volume reduction interventions in routine cli...
Background Severe emphysema is a debilitating condition with few treatment options. Lung volume redu...
Limited guidance exists for the implementation of lung volume reduction interventions in routine cli...
Patients with emphysema frequently complain of exertional dyspnoea despite maximal medical therapy. ...
Background: We determined the feasibility, safety, and short-term efficacy of bronchoscopic placemen...
Resectional lung volume reduction has proven to be superior to medical treatment in reducing dyspnoe...
Pathognomonic features of advanced emphysema include a markedly reduced alveolar surface area due to...
Many patients with emphysema remain breathless despite optimal medical therapy. Non-pharmacological ...
Emphysema is a destructive process of the lung parenchyma characterized by the permanent enlargement...
Endoscopic lung volume reduction using lung sealant is a very new and innovative treatment option fo...
mphysema is an irreversible disease and although patients derive significant benefit from inhaled th...
Chronic obstructive pulmonary disease remains one of the most common causes of morbidity and mortali...
The conventional medical management of emphysema using bronchodilators and anti-inflammatory agents ...
Chronic obstructive pulmonary disease is a group of lung diseases characterized by chronic airflow o...
Severe emphysema is an important problem, affecting ~10 % of people in the USA and is the fourth lea...
Limited guidance exists for the implementation of lung volume reduction interventions in routine cli...
Background Severe emphysema is a debilitating condition with few treatment options. Lung volume redu...
Limited guidance exists for the implementation of lung volume reduction interventions in routine cli...
Patients with emphysema frequently complain of exertional dyspnoea despite maximal medical therapy. ...
Background: We determined the feasibility, safety, and short-term efficacy of bronchoscopic placemen...
Resectional lung volume reduction has proven to be superior to medical treatment in reducing dyspnoe...
Pathognomonic features of advanced emphysema include a markedly reduced alveolar surface area due to...
Many patients with emphysema remain breathless despite optimal medical therapy. Non-pharmacological ...
Emphysema is a destructive process of the lung parenchyma characterized by the permanent enlargement...
Endoscopic lung volume reduction using lung sealant is a very new and innovative treatment option fo...
mphysema is an irreversible disease and although patients derive significant benefit from inhaled th...
Chronic obstructive pulmonary disease remains one of the most common causes of morbidity and mortali...
The conventional medical management of emphysema using bronchodilators and anti-inflammatory agents ...